CT News and Research

RSS

New nanoparticle imaging agent can help diagnose heart disease, breast cancer

Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.

28 Apr 2011

Advanced Orthopaedics & Spine Medicine to participate in iUni G2 knee implant trial

Dr. David Mack of Advanced Orthopaedics & Spine Medicine and North Cypress Medical Center are participating in a ten year follow-up trial of the ConforMIS iUni® G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Performance Orthopedics to participate in iUni G2 knee implant trial

Dr. Gregory Martin of Performance Orthopedics of the Palm Beaches is participating in a ten year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).

27 Apr 2011

Brookside Surgery Center to participate in iUni G2 knee implant trial

Dr. Joseph Burkhardt of Brookside Surgery Center is participating in a ten year follow-up trial of the ConforMIS iUni G2 knee resurfacing device, an FDA cleared implant for patients with osteoarthritic damage in a single compartment of the knee.

27 Apr 2011

Viewpoints: Shortsighted fight against fund to prevent disease; strengthening regulators' control of premium increases

House Republicans are so bent on blocking any and all aspects of health care reform that they have passed a bill that would eliminate a farsighted program — the Prevention and Public Health Fund — intended to help states and communities prevent diseases. Eliminating the fund would save roughly $16 billion over the course of a decade. … The loss to states and local communities would be considerable.

27 Apr 2011

Caliber opens world's largest plant-made pharmaceutical facility in Bryan

Caliber Biotherapeutics, a fully-integrated biopharmaceutical company, announced the opening of the world's largest plant-made pharmaceutical manufacturing facility in Bryan, Texas, with the capability of producing 10-100 million doses of infectious vaccines per month, and hundreds of thousands of doses of protein biotherapeutics such as monoclonal antibodies.

26 Apr 2011

Viewpoints: Sebelius on medical mistakes; Stockman on solving deficit; Fox on Medicare's political history

A recent study found that as many as one out of three hospital patients is harmed by his or her care. And the Institute of Medicine estimates that as many as 100,000 Americans die each year from preventable medical errors in hospitals. That's about the number of annual deaths caused by auto accidents, AIDS, and breast cancer combined.

26 Apr 2011

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANAT®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.

25 Apr 2011

OCM announces acquisition of Diagnostics Plus

One Call Medical, the nation's leading provider of specialty services to insurance payers, today announced its acquisition of Diagnostics Plus, a provider network for advanced radiology and electrodiagnostic services, including MRIs, CT scans, and electromyography.

25 Apr 2011

Epic Imaging receives 100% Mammography Quality Standards Act score

Epic Imaging recently received a 100 percent score on its yearly American College of Radiology Mammography Quality Standards Act inspection.

25 Apr 2011

JVIR articles highlight SIR's commitment to patient safety in medical imaging

The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and reduction of skin dosage; and promoting the safety of patients and health care professionals.

22 Apr 2011

Emerus implements Stockell's suite of Patient Access and Revenue Cycle Management solutions

Stockell Healthcare Systems, Inc. is pleased to announce that Emerus Hospital Partners based in The Woodlands, Texas, has selected the company's InsightCS® Patient Access, Patient Accounting and Revenue Cycle Information software solution.

22 Apr 2011

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance-Georgia (LCA-GA) thanked Senator Johnny Isakson (R-GA) for being an original sponsor of the Lung Cancer Mortality Reduction Act (S. 752), authorizing legislation that establishes a multi-agency, comprehensive research program addressing all aspects of lung cancer, and called on the entire delegation of Georgia to show their support for the lung cancer community.

22 Apr 2011

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.

21 Apr 2011

Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

Pro-Pharmaceuticals, Inc. today announced that the Brussels Branch of the Ludwig Institute for Cancer Research demonstrated the ability of GM-CT-01 (DAVANAT®) to enhance the ability of tumor-specific T-lymphocytes to kill tumor cells.

20 Apr 2011

KCMC uses Toshiba's diagnostic imaging systems to treat pediatric patients

As one of the leading pediatric centers in the United States, Kosair Children's Medical Center (KCMC) treats pediatric patients with conditions ranging from congenital heart disease to abdominal pain, to emergency trauma to juvenile diabetes and pediatric cancer.

20 Apr 2011

Radiology publishes Riverain Medical's SoftView chest X-ray study data in lung cancer

Riverain Medical, an industry leader and innovator in computer-aided detection and advanced visualization technologies, today announced the publication of a peer-reviewed study in Radiology demonstrating that radiologists using Riverain Medical's SoftView bone suppression application with chest X-rays significantly increased their detection of lung nodules proven to be primary lung cancer.

19 Apr 2011

New research: 56% of Canadians with AF do not fear having fatal stroke

New research reveals more than half of Canadians living with atrial fibrillation do not fear having a stroke, despite AF-related strokes being more severe, debilitating and twice as likely to be fatal.

19 Apr 2011

Hospitals can reduce unnecessary imaging tests using CD import

Each year, more than two million critically ill patients are transferred from one hospital emergency department to another for appropriate care. With the ability to successfully import data from a CD-ROM containing the patient's diagnostic medical images, hospitals may be able to significantly reduce unnecessary medical imaging tests, some of which expose patients to radiation. These findings are reported in a new study published in the July issue of Radiology.

19 Apr 2011

CT News and Research

New nanoparticle imaging agent can help diagnose heart disease, breast cancer

Advanced Orthopaedics & Spine Medicine to participate in iUni G2 knee implant trial

Performance Orthopedics to participate in iUni G2 knee implant trial

Boehringer Ingelheim initiates enrollment in BI 201335 Phase 3 clinical trial for chronic HCV

Brookside Surgery Center to participate in iUni G2 knee implant trial

Viewpoints: Shortsighted fight against fund to prevent disease; strengthening regulators' control of premium increases

Caliber opens world's largest plant-made pharmaceutical facility in Bryan

Viewpoints: Sebelius on medical mistakes; Stockman on solving deficit; Fox on Medicare's political history

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

OCM announces acquisition of Diagnostics Plus

Epic Imaging receives 100% Mammography Quality Standards Act score

JVIR articles highlight SIR's commitment to patient safety in medical imaging

Emerus implements Stockell's suite of Patient Access and Revenue Cycle Management solutions

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Ludwig Institute demonstrates ability of DAVANAT to enhance efficacy of T-lymphocytes to kill tumor cells

KCMC uses Toshiba's diagnostic imaging systems to treat pediatric patients

Radiology publishes Riverain Medical's SoftView chest X-ray study data in lung cancer

New research: 56% of Canadians with AF do not fear having fatal stroke

Hospitals can reduce unnecessary imaging tests using CD import

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News